Company profile: Identigen
1.1 - Company Overview
Company description
- Provider of DNA-based solutions to the agri-food industry, applying genetic identification to improve the quality, integrity and safety of the global food supply. Offers DNA TRACEBACK for verifying food origin and production practices, and DATALIVE for animal lifecycle insights to support sustainable business and environmental practices. Operates in Ireland, UK, EU, USA and Canada.
Products and services
- DNA TRACEBACK: Constructs a DNA-based traceability system for food products, using genetic identification to verify origin and production practices and improve supply chain integrity
- Genetic Identification Systems for Food Supply: Engineers a DNA-based assembly applying genetic identification to elevate quality, integrity, and safety across the food supply
- DATALIVE: Architects a data-driven platform offering insights into animals’ life cycle, supporting sustainable business and environmental practices for agri-food operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Identigen
TraitGenetics
HQ: Germany
Website
- Description: Provider of molecular marker development and analysis for biodiversity and plant breeding research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TraitGenetics company profile →
Variant Bio
HQ: United States
Website
- Description: Provider of genomics-driven drug discovery, using whole-genome sequencing and custom algorithms to identify novel, population-specific variants and disease-relevant targets. Offers research partnerships, benefit-sharing programs, and an Affordable Medicines Pledge, plus the Variant Bio Standley Fellowship for genomic data analysis and partnerships with populations with specific health-related traits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Variant Bio company profile →
Tavotek Biotherapeutics
HQ: United States
Website
- Description: Provider of therapeutic medicine discovery, development and commercialization, with platforms and programs including TavoSelect phage display to discover diversified human antibody sequences for biologics and diagnostics; TavoPrecise to develop optimized mono- and multi-specific biologics; TavoELITE to address intracellular undruggable targets; and oncology and immunology therapeutics for cancer, inflammatory and allergic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tavotek Biotherapeutics company profile →
Abeona Therapeutics
HQ: United States
Website
- Description: Provider of gene and cell therapy R&D for rare genetic diseases, including Sanfilippo syndrome types A and B; Recessive Dystrophic Epidermolysis Bullosa (pz-cel, EB-101); and preclinical gene therapies ABO-503 for X-Linked Retinoschisis, ABO-504 for Stargardt Disease, ABO-505 for Autosomal Dominant Optic Atrophy; plus UX111 for MPS IIIA in partnership with Ultragenyx Pharmaceutical Inc.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abeona Therapeutics company profile →
Good Start Genetics
HQ: United States
Website
- Description: Provider of molecular genetic information for reproductive medicine, delivering clinically relevant and actionable insights on inherited genetic disorders to physicians and patients, enabled by a proprietary next-generation sequencing technology platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Good Start Genetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Identigen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Identigen
2.2 - Growth funds investing in similar companies to Identigen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Identigen
4.2 - Public trading comparable groups for Identigen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →